Intervention not reported
Breast cancer stage at the time of presentation: defined as the proportion of women with breast cancer diagnosed at late stage (stage III, IV) Time of outcome assessment: 3 years to 20 years Method of measurement: CBE · health workers
The intervention may leads to lower breast cancer stage at the time of presentation: defined as the… (low certainty).
1 finding from 1 review
Intervention not reported
Accuracy of health worker‐performed CBE Time of outcome assessment: 2 years to 20 years Method of measurement: Sensitivity, specificity and positive predictive value · health workers
1 finding from 1 review
Intervention not reported
CBE coverage Time of outcome assessment: 20 years Method of measurement: active surveillance · health workers
1 finding from 1 review
no estimate extracted
1 study · 1 participants
Moderate
Intervention not reported
Breast cancer mortality: defined as deaths among women who received a diagnosis of breast cancer Time of outcome assessment: 3 years to 20 years Method of measurement: death registration offices, hospital records, and house visits · health workers
It is very uncertain whether the intervention changes breast cancer mortality: defined as deaths among women who received… (very low certainty).
1 finding from 1 review
Intervention not reported
Pain intensity measured on CHQ (0‐100; 0 = worse pain), and VAS (0 to 100; 0 = no pain) Postintervention: first assessment after end of treatment; no later than 3 months · children and adolescents aged 4 years to 18 years, with chronic musculoskeletal pain
1 finding from 1 review
Intervention not reported
Disability measured on CHAQ (0 to 3; 0 = no disability) Postintervention: first assessment after end of treatment; no later than 3 months · children and adolescents aged 4 years to 18 years, with chronic musculoskeletal pain
1 finding from 1 review
Intervention not reported
Quality of life measured on multiple scales (0 to 100; higher score = better quality of life) Postintervention: first assessment after end of treatment; no later than 3 months · children and adolescents aged 4 years to 18 years, with chronic musculoskeletal pain
1 finding from 1 review
Intervention not reported
Outcomes, Time point of assessment · relatives, patients, and healthcare professionals during resucitation
The review found no eligible studies for this question.
1 finding from 1 review
Mobility · people with transtibial amputation due to peripheral arterial disease or diabetes
1 finding from 1 review
Mobility · people with transtibial amputation due to peripheral arterial disease or diabetes
1 finding from 1 review
no estimate extracted
1 study · 8 participants
Very low
Global assessment of efficacy ≥ 50% improvement in pain Medium‐term · adults with low back pain
1 finding from 1 review
Stakeholders' assessment of review quality (final score) Assessed by 2 editors independently using the RQI from 1 to 5 (average of the 2 ratings), higher scores indicate higher quality. · peer reviewers
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Stakeholders' assessment of review quality (change score) Assessed using either:A) a 5‐point scale, change scores range from −4 to 4 (3 studies);B) a 5‐point scale, expressed by "slope of quality score change"(1 study); orC) the MQAI, from −144 to... · peer reviewers
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Global assessment of treatment success · acutely hospitalised older medical patients
1 finding from 1 review
Global assessment of treatment success · acutely hospitalised older medical patients
1 finding from 1 review
Global assessment of treatment success · acutely hospitalised older medical patients
1 finding from 1 review
Global assessment of treatment success · acutely hospitalised medical patients
1 finding from 1 review
Laxation response: patient assessment of change in bowel status at the end of trial · people with cancer and receiving palliative care with opioid‐induced bowel dysfunction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Laxation response: patient assessment of change in bowel status at the end of trial · people with cancer irrespective of whether they were receiving palliative care opioid‐induced bowel dysfunction
1 finding from 1 review
Laxation response: patient assessment of change in bowel status at the end of trial · people receiving palliative care irrespective of whether they had cancer with opioid‐induced bowel dysfunction
Methylnaltrexone may leads to higher laxation response: patient assessment of change in bowel statusgat… compared with placebo (low certainty).
1 finding from 1 review